DIA begins transition to new executive leadership

Monday, December 10, 2012 09:12 AM

DIA, a neutral, global, nonprofit association that provides knowledge resources across the full spectrum of medical product development, announced that Paul Pomerantz, worldwide executive director of DIA, will be leaving effective March 3, 2013, to assume the position of CEO for the American Society of Anesthesiologists.

In the next three months, Pomerantz will work closely with DIA's board of directors to execute a smooth transition that sustains the momentum the organization has achieved under his leadership.

"Paul has been an extraordinary executive director who will be sorely missed, but together we have built a strong foundation for continued growth," said Dr. Ling Su, president of DIA. "We are committed to continuing the implementation of our strategic plan, which is bringing quality programs and services to our members and stakeholders globally. We thank Paul for his contributions and wish him the best of success in his new position."

Under the leadership of Pomerantz, DIA has achieved rapid global expansion and significantly increased its stakeholder relationships—particularly among global health organizations, regulatory agencies and patient groups—driving its transformation into a world-class, knowledge-driven organization.

"This was a very difficult decision to make," Pomerantz said. "The last three years have been among the most fulfilling of my professional career. I am proud of what we accomplished, and confident that DIA's board of directors, staff and volunteers will continue our progress. My new position provides an exciting challenge to serve the needs of a leading medical association and its patients."

The DIA board of directors will announce plans for the executive director search in January.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs